Barclays sets aside further £1bn for mis-selling payouts

Jenna Towler
clock

Barclays has set aside an additional £400m to repay customers mis-sold interest rate hedging products and another £600m for payment protection insurance (PPI) redress.

The bank said the interest rate hedging funds increase followed the Financial Services Authority's (FSA's) report investigating the mis-selilng to small businesses. Barclays has so far set aside £850m, of which £36m had been used as of 31 December 2012. It said the level of provision would be kept under review as the FSA's review progresses.   Barclays also said it would give over another £600m to PPI redress, mainly  as a result of a higher than anticipated response rate to "pro-active mailings in Q4". This bring the total amount to £2.6bn, of which £1.6bn has been used so far.

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Your profession

Feel Good Friday: Quilter pledges £3m towards financial education

Feel Good Friday: Quilter pledges £3m towards financial education

Alongside £1m in grants supporting charities

Professional Adviser
clock 13 February 2026 • 1 min read
Brits unlikely to see IFAs despite Budget impact

Brits unlikely to see IFAs despite Budget impact

Just 19% were likely to seek advice, Continuum finds

Isabel Baxter
clock 12 February 2026 • 3 min read
Treasury consults on AR regime adding further FCA and FOS permissions

Treasury consults on AR regime adding further FCA and FOS permissions

Amid concerns about consumer harm and weaknesses in oversight

Isabel Baxter
clock 12 February 2026 • 3 min read